Neisseria meningitidis is the main cause of meningitis and sepsis, potentially life-threatening
conditions. Thanks to advancements in vaccine development, vaccines are now available …

ABSTRACT Introduction: The 2015 Global Meningococcal Initiative (GMI) meeting discussed
the global importance of meningococcal disease (MD) and its continually changing …

This report compiles and summarizes all recommendations from CDC's Advisory Committee
on Immunization Practices (ACIP) for use of meningococcal vaccines in the United States …

Meningococcal disease describes the spectrum of infections caused by Neisseria
meningiditis, including meningitdis, bacteremia, and bacteremic pneumonia. Two …

Background The meningococcal group B vaccine 4CMenB is a new, recombinant protein-
based vaccine that is licensed to protect against invasive group B meningococcal disease …

Introduction Invasive meningococcal disease (IMD) is uncommon but still causes
considerable public health burden due to its high mortality and morbidity. This review aims …

Invasive meningococcal disease (IMD) caused by Neisseria meningitidis is associated with
high morbidity and mortality. Although IMD incidence is highest in infants, a second peak …

Background Meningococcal conjugate vaccines protect individuals directly, but can also
confer herd protection by interrupting carriage transmission. We assessed the effects of …

Bacterial meningitis and meningococcal sepsis are rare conditions with high case fatality
rates. Early recognition and prompt treatment saves lives. In 1999 the British Infection …

Background Infection with Streptococcus pneumoniae is a major cause of childhood
morbidity and mortality worldwide, especially in low income countries where pneumococcal …